tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bausch + Lomb’s enVista Envy IOL Achieves Key Milestones in Clinical Trial
PremiumCompany AnnouncementsBausch + Lomb’s enVista Envy IOL Achieves Key Milestones in Clinical Trial
1M ago
Bausch + Lomb publishes enVista Envy trial results
Premium
The Fly
Bausch + Lomb publishes enVista Envy trial results
1M ago
Needham medtech & diagnostics analysts hold analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
1M ago
Bausch + Lomb announces Brett Icahn, Gary Hu resign from board
PremiumThe FlyBausch + Lomb announces Brett Icahn, Gary Hu resign from board
2M ago
Bausch + Lomb to Engage in Key September Investor Conferences
Premium
Company Announcements
Bausch + Lomb to Engage in Key September Investor Conferences
2M ago
Bausch + Lomb price target raised to $13 from $11 at BofA
Premium
The Fly
Bausch + Lomb price target raised to $13 from $11 at BofA
3M ago
Bausch + Lomb reports Q2 adjusted EPS 7c, consensus 8c
PremiumThe FlyBausch + Lomb reports Q2 adjusted EPS 7c, consensus 8c
3M ago
Bausch + Lomb raises FY25 revenue view to $5.000B-$5.1050B from $5.000B-$5.100B
Premium
The Fly
Bausch + Lomb raises FY25 revenue view to $5.000B-$5.1050B from $5.000B-$5.100B
3M ago
Bausch + Lomb Confirms Efficacy of LUMIFY Preservative Free Eye Drops
Premium
Company Announcements
Bausch + Lomb Confirms Efficacy of LUMIFY Preservative Free Eye Drops
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100